Opioid Use Disorder: Diagnosis and Treatment
-
Register
- User - $40
This presentation offers a comprehensive exploration of Opioid Use Disorder (OUD), equipping nurse practitioners and healthcare professionals with essential tools to address this growing crisis. Attendees will gain a deeper understanding of the assessment and diagnosis of OUD using DSM-5-TR criteria, along with strategies for managing opioid intoxication, overdose, and withdrawal. The session will also cover evidence-based treatment options, both pharmacological and non-pharmacological, emphasizing a patient-centered approach. With a focus on practical application and current statistics, this engaging and informative talk will prepare participants to effectively recognize and treat OUD, ultimately improving patient outcomes.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.50 Contact Hours; 1.50 are Pharmacology
This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026. PAs should only claim credit commensurate with the extent of their participation
Expiration Date: February 10, 2026
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
• Discuss the assessment and diagnosis of Opioid Use Disorder, using DSM-5-TR diagnostic criteria
• Explain the assessment and treatment of opioid intoxication, overdose, and withdrawal
• Identify options for treatment of opioid use disorder using both pharmacological and non pharmacological interventions.
Rhone D’Errico, DNP, MBA, APRN, PMHNP-BC, FNP-BC, ENP-C, CNE, ACUE
Dr. Rhone D’Errico is a Doctor of Nursing Practice with certifications as a Family, Psychiatric-Mental Health, and Emergency Nurse Practitioner. He has worked as a registered nurse in the neonatal intensive care unit and as a nurse practitioner in mental health, primary care, college health, and the emergency department.
Dr. D’Errico has taught in multiple Family Nurse Practitioner, Psychiatric-Mental Health Nurse Practitioner, Nurse Educator, and Doctor of Nursing Practice Programs. Dr. D’Errico’s passion for nursing education led him to become the founding Program Director for the Psychiatric Mental Health Nurse Practitioner program at the University of Las Vegas, Nevada School of Nursing.
Dr. D’Errico currently holds the rank of Professor in the Rasmussen University School of Nursing, where he serves as Primary Faculty and Track lead for the PMHNP program. He practices via telepsychiatry as the psychiatric provider for a 120+ bed rural intensive inpatient and residential drug treatment program, as well as for a non-profit intensive outpatient drug treatment program. Dr. D’Errico is also a professional speaker, trainer, and educational consultant, and is a candidate daseinanalyst in the American Daseinsanalytic Institute.
Dr. D’Errico’s professional and academic interests include promoting science-based psychiatric diagnosis, improving telehealth delivery in mental health care, and maximizing wellness by leveraging psychopharmacology and existential analysis to help his clients achieve extraordinary results across all areas of life.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Rhone D’Errico, DNP, MBA, APRN, PMHNP-BC, FNP-BC, ENP-C, CNE, ACUE has disclosed no financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
